Shalini Sharp serves as Executive at ANTIGENICS INC /DE/, where they oversee executive responsibilities. Since joining the company, Shalini Sharp has executed 161 insider transactions totaling $18.4M, demonstrating a bearish approach to their equity position. Their most recent transaction on Sep 10, 2009 involved receiving (via award) 5,000 shares valued at $12.0K.
Shalini Sharp currently holds 2,100 shares of ANTIGENICS INC /DE/ (AGEN), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Shalini Sharp has been a net seller of AGEN stock. They have purchased $114.1K and sold $18.3M worth of shares.
Shalini Sharp's most recent insider trade was on Sep 10, 2009, when they sold 5,000 shares at $2.40 per share.
Get notified when new Form 4 filings are submitted
| $1.62 |
| Discretionary |
| Jul 15, 2009 | AGEN | $23.4K | Sale | 13,271 | $1.76 | Discretionary |
| Jul 14, 2009 | AGEN | $0 | Award | 115,200 | $N/A | Discretionary |
| Jan 10, 2009 | AGEN | $0 | Award | 26,201 | $N/A | Discretionary |
| Jan 5, 2009 | AGEN | $0 | Award | 8,000 | $N/A | Discretionary |
| Jul 10, 2008 | AGEN | $0 | Award | 26,201 | $N/A | Discretionary |
| Mar 24, 2008 | AGEN | $0 | Award | 1,667 | $N/A | Discretionary |
| Jan 7, 2008 | AGEN | $0 | Award | 8,000 | $N/A | Discretionary |
| Mar 13, 2007 | AGEN | $9.8K | Purchase | 5,000 | $1.97 | Discretionary |
| Mar 12, 2007 | AGEN | $9.8K | Purchase | 5,000 | $1.95 | Discretionary |